nicardipine has been researched along with rwj 26629 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, WM; Damiano, BP; Salata, JJ; Stump, GL | 1 |
| Jacoby, HI; Lee, DK; Steffler, C; Tomko, KA | 1 |
2 other study(ies) available for nicardipine and rwj 26629
| Article | Year |
|---|---|
In vivo cardiac electrophysiologic effects of RWJ 29009, a new potassium-channel activator, in comparison to cromakalim and nicardipine.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Dogs; Electrocardiography; Female; Heart Conduction System; Male; Nicardipine; Piperidones; Potassium Channels; Pyrans; Pyrroles; Thiophenes; Vasodilator Agents | 1993 |
Vasorelaxant effect of the potassium channel activator, RWJ 29009, is tissue selective.
Topics: Animals; Benzopyrans; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Endothelins; Female; Femoral Artery; In Vitro Techniques; Male; Nicardipine; Nitroprusside; Piperidones; Potassium Channels; Pyrans; Pyrroles; Saphenous Vein; Thiophenes; Vasodilation; Vasodilator Agents | 1993 |